Bayer CEO says the $7.25 billion Roundup settlement could come "any week now," before Christmas

Bayer expects a proposed $7.25 billion settlement of its Roundup weedkiller lawsuits to be completed before Christmas, chief executive Bill Anderson said on Tuesday, according to Reuters. Anderson said it "could be any week now."

What is on the table

The proposed deal is meant to resolve tens of thousands of lawsuits from people who say they developed non-Hodgkin lymphoma or other cancers after using Roundup at home or at work. A Missouri state court judge in St. Louis is reviewing it. Reuters reports Bayer still faces about 65,000 claims in U.S. state and federal courts, and Anderson said far fewer individual cases would remain after the settlement.

Bayer maintains that decades of studies show glyphosate, Roundup's active ingredient, is safe and does not cause cancer. Settling is not an admission otherwise.

The structure behind it

After a Supreme Court win in June, Bayer moved its U.S. Roundup business into a unit called Ruveon and separated it internally from the rest of the company, Reuters reports. That ring-fencing is the detail to watch: it tells investors where the litigation sits and, at least on paper, how far it can reach.

What it means for investors and farmers

For anyone holding Bayer, the open question is timing and certainty, not the headline number. A court-approved settlement caps a large share of the exposure, but Anderson's own wording leaves room for the date to slip, and the remaining individual cases would still need to be resolved. For farmers, lawn-care operators and landscapers who use glyphosate products, nothing in the Reuters report changes what can be sold or applied today.

Bayer shares in Frankfurt (BAYN.DE) closed near 51.84 euros on November 3, within 2.8% of their July 2 high in the past year's trading, per Yahoo Finance data. We did not verify the intraday move that Investing.com's page showed, since its data may be delayed.

Sources: Reuters via Investing.com. Share data from Yahoo Finance. This is market information, not investment advice.